These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Regional versus systemic delivery of recombinant vaccinia virus as suicide gene therapy for murine liver metastases. Gnant MF; Puhlmann M; Bartlett DL; Alexander HR Ann Surg; 1999 Sep; 230(3):352-60; discussion 360-1. PubMed ID: 10493482 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional targeted gene therapy for hepatocellular carcinoma by adenovirus vector. Kanai F Mol Biotechnol; 2001 Jul; 18(3):243-50. PubMed ID: 11503518 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy. Xie Y; Gilbert JD; Kim JH; Freytag SO Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364 [TBL] [Abstract][Full Text] [Related]
10. Enzyme and pathway engineering for suicide gene therapy. Black ME Genet Eng (N Y); 2001; 23():113-27. PubMed ID: 11570100 [No Abstract] [Full Text] [Related]
12. A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy. Freytag SO; Rogulski KR; Paielli DL; Gilbert JD; Kim JH Hum Gene Ther; 1998 Jun; 9(9):1323-33. PubMed ID: 9650617 [TBL] [Abstract][Full Text] [Related]
13. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase. Rogers RP; Ge JQ; Holley-Guthrie E; Hoganson DK; Comstock KE; Olsen JC; Kenney S Hum Gene Ther; 1996 Dec; 7(18):2235-45. PubMed ID: 8953314 [TBL] [Abstract][Full Text] [Related]
14. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice. Gnant MF; Puhlmann M; Alexander HR; Bartlett DL Cancer Res; 1999 Jul; 59(14):3396-403. PubMed ID: 10416601 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy of metastatic colon carcinoma: regression of multiple hepatic metastases by adenoviral expression of bacterial cytosine deaminase. Block A; Freund CT; Chen SH; Nguyen KP; Finegold M; Windler E; Woo SL Cancer Gene Ther; 2000 Mar; 7(3):438-45. PubMed ID: 10766350 [TBL] [Abstract][Full Text] [Related]
17. Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Freytag SO; Khil M; Stricker H; Peabody J; Menon M; DePeralta-Venturina M; Nafziger D; Pegg J; Paielli D; Brown S; Barton K; Lu M; Aguilar-Cordova E; Kim JH Cancer Res; 2002 Sep; 62(17):4968-76. PubMed ID: 12208748 [TBL] [Abstract][Full Text] [Related]
18. Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine. Crystal RG; Hirschowitz E; Lieberman M; Daly J; Kazam E; Henschke C; Yankelevitz D; Kemeny N; Silverstein R; Ohwada A; Russi T; Mastrangeli A; Sanders A; Cooke J; Harvey BG Hum Gene Ther; 1997 May; 8(8):985-1001. PubMed ID: 9195221 [No Abstract] [Full Text] [Related]